Joseph Buscema, MD
Basic profileJoseph Buscema is an Oncology physician affiliated with Tucson Medical Center. OpenAlex indexes 99 publications with 5,682 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GenmabProgram year20254 paymentsResearch$196,293
- Daiichi SankyoProgram year2025245 paymentsResearch$174,446
- GSKProgram year202517 paymentsResearch$53,763
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
40.1%Substance P/Neurokinin-1 Receptor Antagonist32.8%Aprepitant100%Part B, office-administered≥25 patientsSerotonin-3 Receptor Antagonist7.1%Palonosetron hcl59%Granisetron hydrochloride40%Ondansetron Odt2%Part D + Part B≥40 patients+ 3 more classes in this area
Cancer & immunology
25.9%Microtubule Inhibitor24.8%Paclitaxel100%Part B, office-administered≥16 patientsPlatinum-based Drug0.8%Carboplatin100%Part B, office-administered≥16 patients+ 3 more classes in this area
Blood & clotting
19.6%Erythropoiesis-stimulating Agent16.2%Darbepoetin alfa100%Part B, office-administered≥11 patientsIron, parenteral preparations3.3%Ferric derisomaltose100%Part B, office-administered≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Neil Gheewala, MD
Tucson Medical Center
Thomas Waggoner, DO
Tucson Medical Center
Matthew Atlas, MD
Tucson Medical Center
Sudhir Manda, MD
Tucson Medical Center
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”